NETs have demonstrated the ability to activate inflammatory Th17 cells, which secrete IL-17, in diseases related to experimental autoimmune encephalomyelitis (EAE) [11], multiple sclerosis (MS) [158], and myocardial infarction (MI) [159, 160]. This evidence concerns the gene IL17A and myocardial infarction.